Comprehensive structural characterization of commercial rituximab therapeutic monoclonal antibody using high-resolution mass spectrometry

Puntos clave

• To perform detailed structural characterization of rituximab using high-resolution mass spectrometry techniques.
• Employ high-resolution mass spectrometry for thorough characterization of the monoclonal antibody.
• Analyze commercial rituximab products for structural integrity and quality.
• Detailed structural features of rituximab revealed through mass spectrometry techniques.
• Findings enhance understanding of therapeutic monoclonal antibody properties.

Resumen